Daniela Ubiali

Prof. Daniela Ubiali

University of Pavia, Department of Drug Sciences, Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MTMarco Terreni
Marco Terreni
GPGiuseppe Pagani
Giuseppe Pagani
DUDaniela Ubiali
Daniela Ubiali
RFRoberto Fernández-Lafuente
Roberto Fernández-Lafuente
Cesar MateoCesar Mateo
Cesar Mateo
JGJosé M. Guisán
José M. Guisán

1 January 2001 in Journal of Molecular Catalysis B: Enzymatic
Verified
Journal Article
Closed access
IFIsidoro Emilio de Fuentes
Isidoro Emilio de Fuentes
CVCésar Viseras
César Viseras
DUDaniela Ubiali
Daniela Ubiali
MTMarco Terreni
Marco Terreni
Andrés R. AlcántaraAndrés R. Alcántara
Andrés R. Alcántara

8 September 2004 in Biomacromolecules
Verified
Journal Article
Closed access
SRSilvia Rocchietti
Silvia Rocchietti
DUDaniela Ubiali
Daniela Ubiali
MTMarco Terreni
Marco Terreni
AAAlessandra M. Albertini
Alessandra M. Albertini
RFRoberto Fernández-Lafuente
Roberto Fernández-Lafuente
MPMassimo Pregnolato
Massimo Pregnolato

29 September 2004 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
DUDaniela Ubiali
Daniela Ubiali
SRSilvia Rocchietti
Silvia Rocchietti
FSFrancesca Scaramozzino
Francesca Scaramozzino
MTMarco Terreni
Marco Terreni
AAAlessandra M. Albertini
Alessandra M. Albertini
MPMassimo Pregnolato
Massimo Pregnolato

12 April 2019 in Catalysts
Verified
Journal Article
Open access
PDF file
MRMarco Rabuffetti
Marco Rabuffetti
Teodora BavaroTeodora Bavaro
Teodora Bavaro
RSRiccardo Semproli
Riccardo Semproli
GCGiulia Cattaneo
Giulia Cattaneo
MMMichela Massone
Michela Massone
DUDaniela Ubiali
Daniela Ubiali
Despite the impressive progress in nucleoside chemistry to date, the synthesis of nucleoside analogues is still a challenge. Chemoenzymatic synthesis has been proven to overcome most of the constraints of conventional nucleoside chemistry. A purine nucleoside phosphorylase from Aeromonas hydrophila (AhPNP) has been used herein to catalyze the synthesis of Ribavirin, Tecadenoson, and Cladribine, by a “one-pot, one-enzyme” transglycosylation, which is the transfer of the carbohydrate moiety from a nucleoside donor to a heterocyclic base. As the sugar donor, 7-methylguanosine iodide and its 2′-deoxy counterpart were synthesized and incubated either with the “purine-like” base or the modified purine of the three selected APIs. Good conversions (49–67%) were achieved in all cases under screening conditions. Following this synthetic scheme, 7-methylguanine arabinoside iodide was also prepared with the purpose to synthesize the antiviral Vidarabine by a novel approach. However, in this case, neither the phosphorolysis of the sugar donor, nor the transglycosylation reaction were observed. This study was enlarged to two other ribonucleosides structurally related to Ribavirin and Tecadenoson, namely, Acadesine, or AICAR, and 2-chloro-N6-cyclopentyladenosine, or CCPA. Only the formation of CCPA was observed (52%). This study paves the way for the development of a new synthesis of the target APIs at a preparative scale. Furthermore, the screening herein reported contributes to the collection of new data about the specific substrate requirements of AhPNP.

1 June 2020 in Acta Chromatographica
Verified
Journal Article
Open access
PDF file
Stefano DugheriStefano Dugheri
Stefano Dugheri
NMNicola Mucci
Nicola Mucci
ABAlessandro Bonari
Alessandro Bonari
GMGiorgio Marrubini
Giorgio Marrubini
GCGiovanni Cappelli
Giovanni Cappelli
GAGiulio Arcangeli
Giulio Arcangeli
Sample pretreatment is the first and the most important step of an analytical procedure. In routine analysis, liquid–liquid microextraction (LLE) is the most widely used sample pre-treatment technique, whose goal is to isolate the target analytes, provide enrichment, with cleanup to lower the chemical noise, and enhance the signal. The use of extensive volumes of hazardous organic solvents and production of large amounts of waste make LLE procedures unsuitable for modern, highly automated laboratories, expensive, and environmentally unfriendly. In the past two decades, liquid-phase microextraction (LPME) was introduced to overcome these drawbacks. Thanks to the need of only a few microliters of extraction solvent, LPME techniques have been widely adopted by the scientific community. The aim of this review is to report on the state-of-the-art LPME techniques used in gas and liquid chromatography. Attention was paid to the classification of the LPME operating modes, to the historical contextualization of LPME applications, and to the advantages of microextraction in methods respecting the value of green analytical chemistry. Technical aspects such as description of methodology selected in method development for routine use, specific variants of LPME developed for complex matrices, derivatization, and enrichment techniques are also discussed.